RecruitingNot Applicable

Combined Motor Imagery and Vestibular Rehab for MS

Turkey (Türkiye)30 participantsStarted 2025-12-01

Plain-language summary

This trial investigates the first combined use of motor imagery and vestibular rehabilitation in multiple sclerosis, aiming to evaluate their joint effect on balance, cognition, and quality of life.

Who can participate

Age range18 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosis of Multiple Sclerosis (MS) Confirmed using McDonald Criteria
✓. Patient diagnosed relapsing-remitting multiple sclerosis (RRMS).
✓. Mild MS between 0-3 according to PDDS.
✓. Age from (18-45)
✓. Mild cognitive impairment
✓. Balance impairment (mild to moderate impairment)
✓. Vestibular dysfunction Related to MS (dizziness, vertigo , gaze instability ) 8. Native language is Arabic to ensure clear communication during cognitive tasks and exercise instructions

What they're measuring

Change in Cognitive Function (Montreal Cognitive Assessment [MoCA] Score)

Timeframe: Baseline and 8 weeks after intervention

Change in Balance Berg Balance Scale \[ABBS] Score)

Timeframe: Baseline (Week 0) and Post-intervention (Week 8)

Change in Vestibular Function (Dynamic Visual Acuity [DVA] Test)

Timeframe: Baseline and Week 8.

Change in Vestibular Function (Head Impulse Test [HIT])

Timeframe: Baseline and Week 8

Change in Cognitive Function (Brief International Cognitive Assessment for MS \[BICAMS] Composite Score

Timeframe: Baseline (Week 0) and Post-intervention (Week 8)

Change in balance (Timed Up and Go [TUG] Time)

Timeframe: Baseline and Week 8

Change in Disability Status (Patient-Determined Disease Steps \[PDDS] Score)

Timeframe: Baseline and Week 8.

Trial details

NCT IDNCT07230015

SponsorMedipol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-05-30

Contact for this trial

Gehad Salem menshawi, PT, MSc (Cand.)

+201040131964 j.menshawi@hotmail.com

View on ClinicalTrials.gov More Multiple Sclerosis (MS) - Relapsing-remitting trials

Who can participate

Age range18 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosis of Multiple Sclerosis (MS) Confirmed using McDonald Criteria
✓. Patient diagnosed relapsing-remitting multiple sclerosis (RRMS).
✓. Mild MS between 0-3 according to PDDS.
✓. Age from (18-45)
✓. Mild cognitive impairment
✓. Balance impairment (mild to moderate impairment)
✓. Vestibular dysfunction Related to MS (dizziness, vertigo , gaze instability ) 8. Native language is Arabic to ensure clear communication during cognitive tasks and exercise instructions

What they're measuring

Change in Cognitive Function (Montreal Cognitive Assessment [MoCA] Score)

Timeframe: Baseline and 8 weeks after intervention

Change in Balance Berg Balance Scale \[ABBS] Score)

Timeframe: Baseline (Week 0) and Post-intervention (Week 8)

Change in Vestibular Function (Dynamic Visual Acuity [DVA] Test)

Timeframe: Baseline and Week 8.

Change in Vestibular Function (Head Impulse Test [HIT])

Timeframe: Baseline and Week 8

Change in Cognitive Function (Brief International Cognitive Assessment for MS \[BICAMS] Composite Score

Timeframe: Baseline (Week 0) and Post-intervention (Week 8)

Change in balance (Timed Up and Go [TUG] Time)

Timeframe: Baseline and Week 8

Change in Disability Status (Patient-Determined Disease Steps \[PDDS] Score)

Timeframe: Baseline and Week 8.